Cargando…

Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis

BACKGROUND: To analyze differences in the recognition of anti-citrullinated peptide/protein antibody (ACPA) citrullinated epitopes and isotypes in patients with palindromic rheumatism (PR) and rheumatoid arthritis (RA). METHODS: ACPA fine specificities (citrullinated peptides of enolase, fibrin, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabrera-Villalba, Sonia, Gomara, María José, Cañete, Juan D., Ramírez, Julio, Salvador, Georgina, Ruiz-Esquide, Virginia, Hernández, Maria Victoria, Inciarte-Mundo, José, Haro, Isabel, Sanmartí, Raimon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472877/ https://www.ncbi.nlm.nih.gov/pubmed/28619044 http://dx.doi.org/10.1186/s13075-017-1329-6

Ejemplares similares

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis
por: Castellanos-Moreira, Raul, et al.
Publicado: (2020)

Palindromic Rheumatism: Just a Pre-rheumatoid Stage or Something Else?
por: Sanmartí, Raimon, et al.
Publicado: (2021)

Calprotectin and TNF trough serum levels identify power Doppler ultrasound synovitis in rheumatoid arthritis and psoriatic arthritis patients in remission or with low disease activity
por: Inciarte-Mundo, José, et al.
Publicado: (2016)

Calprotectin strongly and independently predicts relapse in rheumatoid arthritis and polyarticular psoriatic arthritis patients treated with tumor necrosis factor inhibitors: a 1-year prospective cohort study
por: Inciarte-Mundo, José, et al.
Publicado: (2018)

Differences in synovial fluid cytokine levels but not in synovial tissue cell infiltrate between anti-citrullinated peptide/protein antibody-positive and –negative rheumatoid arthritis patients
por: Gómez-Puerta, José A, et al.
Publicado: (2013)

Implications of Post-Translational Modifications in Autoimmunity with Emphasis on Citrullination, Homocitrullination and Acetylation for the Pathogenesis, Diagnosis and Prognosis of Rheumatoid Arthritis
por: Haro, Isabel, et al.
Publicado: (2022)

Development of a multiplex assay based on chimeric citrullinated peptides as proof of concept for diagnosis of rheumatoid arthritis
por: García-Moreno, Cristina, et al.
Publicado: (2019)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis
por: Sanmartí, Raimon, et al.
Publicado: (2009)

Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

Immunopathologic characterization of ultrasound-defined synovitis in rheumatoid arthritis patients in clinical remission
por: Ramírez, Julio, et al.
Publicado: (2016)

Palindromic Rheumatism
Publicado: (1943)

Palindromic Rheumatism
por: Mattingly, S., et al.
Publicado: (1981)

Patients with rheumatoid arthritis in clinical remission and ultrasound-defined active synovitis exhibit higher disease activity and increased serum levels of angiogenic biomarkers
por: Ramírez, Julio, et al.
Publicado: (2014)

Peptides Bearing Multiple Post-Translational Modifications as Antigenic Targets for Severe Rheumatoid Arthritis Patients
por: García-Moreno, Cristina, et al.
Publicado: (2021)

Calprotectin in Patients with Rheumatic Immunomediated Adverse Effects Induced by Checkpoints Inhibitors
por: Frade-Sosa, Beatriz, et al.
Publicado: (2023)

Prognostic Factors in Palindromic Rheumatism
por: Grattan, C. E. H., et al.
Publicado: (1984)

Iguratimod efficacy in palindromic rheumatism treatment
por: Yuan, Fangfang, et al.
Publicado: (2023)

High Sensitivity C Reactive Protein in Patients with Rheumatoid Arthritis Treated with Antibodies against IL-6 or Jak Inhibitors: A Clinical and Ultrasonographic Study
por: Frade-Sosa, Beatriz, et al.
Publicado: (2022)

Anticitrullinated peptide antibodies (ACPA) in the serum of heavy smokers without arthritis - a differential role of associated pulmonary disease?
por: Ruiz-Esquide, V, et al.
Publicado: (2010)

Development of anti-citrullinated protein antibody and rheumatoid factor isotypes prior to the onset of rheumatoid arthritis
por: Bos, Wouter H, et al.
Publicado: (2014)

Synovial lymphoid neogenesis is associated with IL-23 expression and disease activity in rheumatoid arthritis
por: Cañete, Juan D, et al.
Publicado: (2011)

Antibodies against citrullinated proteins of IgA isotype are associated with progression to rheumatoid arthritis in individuals at-risk
por: Sokolova, Maria V, et al.
Publicado: (2023)

Imaging Findings in Patients with Immune Checkpoint Inhibitor-Induced Arthritis
por: Ponce, Andrés, et al.
Publicado: (2022)

Predictive model to identify multiple failure to biological therapy in patients with rheumatoid arthritis
por: Novella-Navarro, Marta, et al.
Publicado: (2022)

Isotypes of Epstein-Barr Virus Antibodies in Rheumatoid Arthritis: Association with Rheumatoid Factors and Citrulline-Dependent Antibodies
por: Westergaard, Marie Wulff, et al.
Publicado: (2015)

Is palindromic rheumatism amongst children a benign disease?
por: Butbul-Aviel, Yonatan, et al.
Publicado: (2018)

Palindromic Rheumatism Frequently Precedes Early Rheumatoid Arthritis: Results From an Incident Cohort
por: Ellingwood, L., et al.
Publicado: (2019)

Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
por: Brink, Mikael, et al.
Publicado: (2016)

Rosai-Dorfman-Destombes (RDD) disease presenting as palindromic rheumatism
por: Haghighat Jahromi, Amin, et al.
Publicado: (2021)

Lower peripheral helper T cell levels in the synovium are associated with a better response to anti-TNF therapy in rheumatoid arthritis
por: Julià, Antonio, et al.
Publicado: (2020)

Antibodies to Citrullinated Protein Antigens, Rheumatoid Factor Isotypes and the Shared Epitope and the Near-Term Development of Clinically-Apparent Rheumatoid Arthritis
por: Bergstedt, Dylan T., et al.
Publicado: (2022)

Risk of autoimmune rheumatic diseases in patients with palindromic rheumatism: A nationwide, population-based, cohort study
por: Chen, Hsin-Hua, et al.
Publicado: (2018)

Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis
por: Kokkonen, Heidi, et al.
Publicado: (2011)

Synovial Immunohistological Biomarkers of the Classification of Undifferentiated Arthritis Evolving to Rheumatoid or Psoriatic Arthritis
por: Cuervo, Andrea, et al.
Publicado: (2021)

Upadacitinib for Patients with Rheumatoid Arthritis: A Comprehensive Review
por: Sanmartí, Raimon, et al.
Publicado: (2023)

Immature Blood Vessels in Rheumatoid Synovium Are Selectively Depleted in Response to Anti-TNF Therapy
por: Izquierdo, Elena, et al.
Publicado: (2009)

Myocardial Infarction in a Young Female with Palindromic Rheumatism: A Consequence of Negative Remodeling
por: Larsen, Timothy R., et al.
Publicado: (2012)

Relapsing periodic arthritis, palindromic rheumatism and MEFV gene-related variants alleles in children
por: Salehzadeh, Farhad, et al.
Publicado: (2019)

Clinical Analysis of Behcet Disease: Arthritic Manifestations in Behcet Disease may present as Seronegative Rheumatoid Arthritis or Palindromic Rheumatism
por: Park, Jae-Ho
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_tu695i9ng0vl3o6mg3ihu7ecdg